Target Price | $27.33 |
Price | $3.98 |
Potential |
586.77%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Oncternal Therapeutics Inc 2025 .
The average Oncternal Therapeutics Inc target price is $27.33.
This is
586.77%
register free of charge
$39.00
879.90%
register free of charge
$18.00
352.26%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Oncternal Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Oncternal Therapeutics Inc stock has an average upside potential 2025 of
586.77%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.79 | 1.70 |
46.98% | 114.77% | |
Net Margin | -5,032.00% | -1,988.84% |
50.77% | 60.48% |
3 Analysts have issued a sales forecast Oncternal Therapeutics Inc 2024 . The average Oncternal Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Oncternal Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Oncternal Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -13.43 | -11.40 |
20.06% | 15.12% | |
P/E | negative | |
EV/Sales | negative |
3 Analysts have issued a Oncternal Therapeutics Inc forecast for earnings per share. The average Oncternal Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Oncternal Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Oncternal Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.